Evidence map›Paper›PMID 28512094›Full record

ArticlemBio2017

Intrinsic Toxin-Derived Peptides Destabilize and Inactivate

Jason L Larabee, Sarah J Bland, Jonathan J Hunt, Jimmy D Ballard

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Mouse monoclonal antibodies againstInfection and immunity · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Toxin B Variants fromToxins · 2019
    Article
  12. Article
  13. Review
  14. Cell-penetrating peptides derived fromThe Journal of biological chemistry · 2018
    Article
  15. The Conserved Cys-2232 inFrontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jason L LarabeeDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA jason-larabee@ouhsc.edu.
Sarah J BlandDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Jonathan J HuntDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Jimmy D BallardDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
University of Oklahoma Health Sciences Center · US

Funding

Differential Effects of TcdB1 and TcdB2 in C. difficile diseaseR01AI119048 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BALLARD, JIMMY D. · 2015 to 2024
$3.8M
Characterization of a C. difficile Toxin-Encoded Cell Penetrating PeptideR21AI121925 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BALLARD, JIMMY D. · 2016 to 2017
$407k
NIAID NIH HHS R01 AI119048NIAID NIH HHS R21 AI121925
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBacterial ProteinsBacterial ToxinsCell Line, TumorCHO CellsClostridioides difficileClostridium InfectionsCricetulusEpitopesHumansPeptide FragmentsVirulence FactorsBacterial ProteinsBacterial ToxinsEpitopesPeptide FragmentstoxB protein, Clostridium difficileVirulence FactorsClostridium difficileexotoxinspeptidesTcdB

Identifiers

PMID28512094
PMCPMC5433098
OpenAlexW2615567838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.